These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32270839)

  • 1. Chlorination versus hydroxylation selectivity mediated by the non-heme iron halogenase WelO5.
    Zhang X; Wang Z; Gao J; Liu W
    Phys Chem Chem Phys; 2020 Apr; 22(16):8699-8712. PubMed ID: 32270839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontier Molecular Orbital Contributions to Chlorination versus Hydroxylation Selectivity in the Non-Heme Iron Halogenase SyrB2.
    Srnec M; Solomon EI
    J Am Chem Soc; 2017 Feb; 139(6):2396-2407. PubMed ID: 28095695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for halogenation by iron- and 2-oxo-glutarate-dependent enzyme WelO5.
    Mitchell AJ; Zhu Q; Maggiolo AO; Ananth NR; Hillwig ML; Liu X; Boal AK
    Nat Chem Biol; 2016 Aug; 12(8):636-40. PubMed ID: 27348090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of an open active site conformation of nonheme iron halogenase CytC3.
    Wong C; Fujimori DG; Walsh CT; Drennan CL
    J Am Chem Soc; 2009 Apr; 131(13):4872-9. PubMed ID: 19281171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate positioning controls the partition between halogenation and hydroxylation in the aliphatic halogenase, SyrB2.
    Matthews ML; Neumann CS; Miles LA; Grove TL; Booker SJ; Krebs C; Walsh CT; Bollinger JM
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17723-8. PubMed ID: 19815524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-principles study of non-heme Fe(II) halogenase SyrB2 reactivity.
    Kulik HJ; Blasiak LC; Marzari N; Drennan CL
    J Am Chem Soc; 2009 Oct; 131(40):14426-33. PubMed ID: 19807187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regioselectivity of substrate hydroxylation versus halogenation by a nonheme iron(IV)-oxo complex: possibility of rearrangement pathways.
    Quesne MG; de Visser SP
    J Biol Inorg Chem; 2012 Aug; 17(6):841-52. PubMed ID: 22580819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Study of Chemoselectivity for Carbon Radical Hydroxylation versus Chlorination with Fe
    Yang M; Chen X; Su X; She YB; Yang YF
    Chem Asian J; 2023 Mar; 18(6):e202201311. PubMed ID: 36705485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective C-H halogenation over hydroxylation by non-heme iron(iv)-oxo.
    Rana S; Biswas JP; Sen A; Clémancey M; Blondin G; Latour JM; Rajaraman G; Maiti D
    Chem Sci; 2018 Oct; 9(40):7843-7858. PubMed ID: 30429994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic Structure of the Ferryl Intermediate in the α-Ketoglutarate Dependent Non-Heme Iron Halogenase SyrB2: Contributions to H Atom Abstraction Reactivity.
    Srnec M; Wong SD; Matthews ML; Krebs C; Bollinger JM; Solomon EI
    J Am Chem Soc; 2016 Apr; 138(15):5110-22. PubMed ID: 27021969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Non-Heme Iron Halogenases: High-Spin Oxoiron(IV)-Halide Complexes That Halogenate C-H Bonds.
    Puri M; Biswas AN; Fan R; Guo Y; Que L
    J Am Chem Soc; 2016 Mar; 138(8):2484-7. PubMed ID: 26875530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific alkane hydroxylation by non-heme iron catalysts: mechanistic evidence for an Fe(V)=O active species.
    Chen K; Que L
    J Am Chem Soc; 2001 Jul; 123(26):6327-37. PubMed ID: 11427057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of the Fe(IV)=O intermediate in the catalytic cycle of the halogenase SyrB2.
    Wong SD; Srnec M; Matthews ML; Liu LV; Kwak Y; Park K; Bell CB; Alp EE; Zhao J; Yoda Y; Kitao S; Seto M; Krebs C; Bollinger JM; Solomon EI
    Nature; 2013 Jul; 499(7458):320-3. PubMed ID: 23868262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation and structure of the ferryl [Fe[double bond, length as m-dash]O] intermediate in the non-haem iron halogenase SyrB2: classical and QM/MM modelling agree.
    Rugg G; Senn HM
    Phys Chem Chem Phys; 2017 Nov; 19(44):30107-30119. PubMed ID: 29099125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and Functional Insights into a Nonheme Iron- and α-Ketoglutarate-Dependent Halogenase That Catalyzes Chlorination of Nucleotide Substrates.
    Dai L; Zhang X; Hu Y; Shen J; Zhang Q; Zhang L; Min J; Chen CC; Liu Y; Huang JW; Guo RT
    Appl Environ Microbiol; 2022 May; 88(9):e0249721. PubMed ID: 35435717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in substrate hydroxylation reactions by heme and nonheme iron(IV)-oxo oxidants give correlations between intrinsic properties of the oxidant with barrier height.
    de Visser SP
    J Am Chem Soc; 2010 Jan; 132(3):1087-97. PubMed ID: 20041691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O
    Solomon EI; Goudarzi S; Sutherlin KD
    Biochemistry; 2016 Nov; 55(46):6363-6374. PubMed ID: 27792301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolved Aliphatic Halogenases Enable Regiocomplementary C-H Functionalization of a Pharmaceutically Relevant Compound.
    Hayashi T; Ligibel M; Sager E; Voss M; Hunziker J; Schroer K; Snajdrova R; Buller R
    Angew Chem Int Ed Engl; 2019 Dec; 58(51):18535-18539. PubMed ID: 31589798
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zhu Q; Liu X
    Beilstein J Org Chem; 2017; 13():1168-1173. PubMed ID: 28684995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Do Electrostatic Perturbations of the Protein Affect the Bifurcation Pathways of Substrate Hydroxylation versus Desaturation in the Nonheme Iron-Dependent Viomycin Biosynthesis Enzyme?
    Ali HS; Henchman RH; Warwicker J; de Visser SP
    J Phys Chem A; 2021 Mar; 125(8):1720-1737. PubMed ID: 33620220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.